Latest News of TRVI
Institutional investors in Trevi Therapeutics, Inc. (NASDAQ:TRVI) see US$40m decrease in market cap last week, although long-term gains have benefitted them.
By Yahoo! Finance |
1 month ago
Ownership research and analyst forecasts data provide insights into stock opportunities. Institutions hold 37% stake in Trevi Therapeutics, impacting market cap fluctuations. Hedge funds and private e...
Here's Why We're Not Too Worried About Trevi Therapeutics' (NASDAQ:TRVI) Cash Burn Situation
By Yahoo! Finance |
2 months ago
Investors are attracted to unprofitable companies like Salesforce.com, but they must be cautious of those that burn through cash and collapse. Trevi Therapeutics has a cash runway of 2....